Turning the tide on antibiotic resistance will require new ways of working, writes executive director of the Global ...

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...

La Jolla scientists are stepping into a national push to get new medicines from lab bench to bedside faster. The project, ...

Sanford Burnham Prebys is one of several institutions contributing to the federally funded project called PREDICTS ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Dana-Farber CEO outlines 2026 priorities: AI research, rare disease drug development, and plans for a new 300-bed hospital.

The Congressional Budget Office (CBO) informs Congress about the costs or revenue changes associated with proposed legislation, a challenging enough task on its own. Sometimes, the CBO is asked to ...

It took 27 years, but Cytokinetics secured its first U.S. drug approval. On Friday, the Food and Drug Administration cleared ...

Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the ...

Millions of osteoporosis patients worldwide are set to benefit from a major international breakthrough, which will transform ...

Ace Therapeutics recently launched in vivo efficacy testing services for IBD drug candidates. Ace Therapeutics, a preclinical ...